Free Trial

Vincerx Pharma (VINC) SEC Filings & 10K Form

Vincerx Pharma logo
$1.24 -0.01 (-0.80%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.24 +0.00 (+0.08%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vincerx Pharma SEC Filings

DateFilerForm TypeView
02/12/2025
7:30 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:09 PM
Long Focus Capital Management, LLC (Filed by)
Vincerx Pharma (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:06 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/29/2025
3:05 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/23/2025
3:10 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:15 PM
Vincerx Pharma (Filer)
Form DEFA14A
01/21/2025
3:31 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:29 PM
Vincerx Pharma (Filer)
Form 424B5
01/16/2025
4:11 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:12 PM
Vincerx Pharma (Filer)
Form 424B5
12/27/2024
3:13 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
4:05 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/13/2024
7:32 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
11/05/2024
8:15 AM
Vincerx Pharma (Filer)
Form PRE 14A
09/30/2024
5:57 AM
Vincerx Pharma (Subject)
Form SC TO-I/A
09/10/2024
3:02 PM
Vincerx Pharma (Subject)
Form SC TO-I/A
08/16/2024
3:01 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:11 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:00 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:03 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
7:07 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:37 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Vincerx Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
3:45 PM
Vincerx Pharma (Filer)
Form DEF 14A
05/29/2024
7:54 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
7:55 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:03 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
8:12 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:35 PM
Bushnell Laura I. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:36 PM
Stevens Ruth E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:36 PM
Lee John H. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:38 PM
Salva Francisco D. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:40 PM
Druker Brian (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:06 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:21 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
8:00 AM
Prosight Management, LP (Filed by)
Vincerx Pharma (Subject)
Form SC 13G
04/29/2024
4:14 PM
Vincerx Pharma (Filer)
Form 424B5
04/10/2024
3:03 PM
Vincerx Pharma (Filer)
Form DEFA14A
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
04/10/2024
3:09 PM
Vincerx Pharma (Filer)
Form ARS
04/09/2024
4:09 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Vincerx Pharma (Subject)
Form SC 13G/A
04/08/2024
3:35 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:12 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
2:14 PM
Vincerx Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2024
2:26 PM
Vincerx Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
6:58 PM
THOMAS TOM C (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:00 PM
Hamdy Ahmed MD (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:04 PM
Seelenberger Alexander A. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
7:08 PM
Izumi Raquel E. (Reporting)
Vincerx Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VINC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners